Send the following on WhatsApp
Continue to ChatFDA 批准膽管癌新藥,日本大鵬藥品 Lytgobi 新型 FGFR 抑制劑將上市 https://geneonline.news/cholangiocarcinoma-fda-approval-fgfr-inhibitor/
FDA 批准膽管癌新藥,日本大鵬藥品 Lytgobi 新型 FGFR 抑制劑將上市 https://geneonline.news/cholangiocarcinoma-fda-approval-fgfr-inhibitor/